New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
OverviewChart

Quote Panel

Shape
Updated October 16, 2025
1W % 1M % 3M % 1Y -21.03 %

Key Metrics

Shape

  • Market Cap

    71.75M

  • Shares Outstanding

    7.77M

  • Share in Float

    127892

  • Dividende

    0

  • Earning Date

    No Data

  • Price Target

    9.24

  • Average Volume

    2736

  • Beta

    0.048

  • Range

    8.05-15.8

  • Industry

    Shell Companies

  • Website

  • Sector

    Financial Services

Fundamentals

Shape

Relative Strength

Shape

PWUP

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

N/A

N/A

2025-Revenue

N/A

N/A

2025-EPS

N/A

N/A

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

0.08
vs NA

Q2.23

arrow
arrow

N/A

0.09
vs NA

Q3.23

arrow
arrow

N/A

0.04
vs NA

Q4.23

arrow
arrow

N/A

NA
vs 0.13

Q1.24

arrow
arrow

N/A

NA
vs 0.08

Q2.24

arrow
arrow

N/A

NA
vs 0.09

Q3.24

arrow
arrow

N/A

NA
vs 0.04

Q4.24

arrow
arrow

N/A

NA
vs NA

Q1.25

arrow
arrow

N/A

NA
vs NA

Q2.25

arrow
arrow

N/A

NA
vs NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

NA

NA  vs NA

Q1.25

arrow
arrow

NA

NA  vs NA

Q2.25

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+1%

0.01
vs 0.01

Q2.23

arrow
arrow

+9%

0.09
vs 0.01

Q3.23

arrow
arrow

0%

-0.00
vs 0.09

Q4.23

arrow
arrow

-1%

-0.01
vs -0.00

Q1.24

arrow
arrow

-14%

-0.14
vs -0.01

Q2.24

arrow
arrow

-96%

-0.96
vs -0.14

Q3.24

arrow
arrow

-595%

-5.95
vs -0.96

Q4.24

arrow
arrow

-149%

-1.49
vs -5.95

Q1.25

arrow
arrow

+229%

2.29
vs -1.49

Q2.25

arrow
arrow

+21%

0.21
vs 2.29

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

59

59
vs 52

13%

Q4.22

arrow
arrow

59

59
vs 59

NA

Q1.23

arrow
arrow

59

59
vs 59

NA

Q2.23

arrow
arrow

13

13
vs 59

-78%

Q3.23

arrow
arrow

20

20
vs 13

54%

Q4.23

arrow
arrow

20

20
vs 20

NA

Q1.24

arrow
arrow

19

19
vs 20

-5%

Q2.24

arrow
arrow

2

2
vs 19

-89%

Q3.24

arrow
arrow

2

2
vs 2

NA

Q4.24

arrow
arrow

3

3
vs 2

50%

Earnings Growth

Latest News

PWUP

accessnewswire.com

7 hours ago

Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
PWUP

globenewswire.com

8 hours ago

Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements
PWUP

globenewswire.com

8 hours ago

Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.
PWUP

accessnewswire.com

13 hours ago

Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
PWUP

accesswire.com

13 hours ago

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers of PWUP, ESGR
PWUP

prnewswire.com

19 hours ago

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers of PWUP and ESGR